CELLERON THERAPEUTICS

Updated 5 days ago
Private Limited Company
  • Active - 05162047 (CH)
  • Age: 19 years
  • ID: 20265278/128
Magdalen Centre Oxford Science Park Robert Robinson Avenue Oxford, OX4 4GA
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
• 72110 - Research and experimental development on biotechnology
Our Mission is to develop safe and effective treatments for unmet cancers through science and innovation... We were formed in January 2023 through the merger of Oxford University spinouts Celleron Therapeutics Ltd. ("Celleron") and Argonaut Therapeutics Ltd. ("Argonaut"), bringing together drug discovery and clinical development capabilities. The combination streamlines our research and development processes and ensures the continuity of our clinical development pipeline... We focus on developing new precision medicine drugs and cancer vaccines to destroy immunologically cold tumours.
Also known as: CELLERON THERAPEUTICS LIMITED, Celleron Therapeutics Ltd.
Registration numbers: 05162047 (CH)
Primary location: Oxford United Kingdom
Associated domains: argonauttherapeutics.co.uk
  • 0
  • 0
Interest Score
1
HIT Score
0.60
CFO
Bill Fleming
COO
Collette Coll
Chairman
James Noble
General
en..@cellerontherapeutics.com, en..@ingenox.com, en..@ingenox.com, en..@ingenoxtherapeutics.com

UK Company Data

Company number
05162047		 Account category
TOTAL EXEMPTION FULL		 Account ref. day
30		 Account ref. month
6
Accounts next due date
2025-03-31		 Accounts last made up date
2023-06-30		 Returns next due date
2017-07-22		 Returns last made up date
2016-06-24
Num. mort. charges
1		 Num. mort. outstanding
0		 Num. mort. part. satisfied
0		 Num. mort. satisfied
1
Num. gen. partners
0		 Num. lim. partners
0
Domain
cellerontherapeutics.com
Actual
ingenox.com
IP
95.179.239.122
Status
OK
Category
Company
0 comments Add a comment